168 related articles for article (PubMed ID: 19890436)
1. Research Highlights from the Purdue-UAB Botanicals Research Center for Age Related Diseases.
Weaver CM; Barnes S; Wyss JM; Kim H; Morré DM; Morré DJ; Simon JE; Lila MA; Janle EM; Ferruzzi MG
Pharm Biol; 2009 Aug; 47(8):768-773. PubMed ID: 19890436
[TBL] [Abstract][Full Text] [Related]
2. Botanicals for age-related diseases: from field to practice.
Weaver CM; Barnes S; Wyss JM; Kim H; Morré DM; Morré DJ; Simon JE; Lila MA; Janle EM; Ferruzzi MG
Am J Clin Nutr; 2008 Feb; 87(2):493S-7S. PubMed ID: 18258645
[TBL] [Abstract][Full Text] [Related]
3. Botanicals and Their Bioactive Phytochemicals for Women's Health.
Dietz BM; Hajirahimkhan A; Dunlap TL; Bolton JL
Pharmacol Rev; 2016 Oct; 68(4):1026-1073. PubMed ID: 27677719
[TBL] [Abstract][Full Text] [Related]
4. Research highlights from the UIC/NIH Center for Botanical Dietary Supplements Research for Women's Health: Black cohosh from the field to the clinic.
Farnsworth NR; Mahady GB
Pharm Biol; 2009 Aug; 47(8):755-760. PubMed ID: 20161501
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for Development of Botanical Polyphenols as "Natural Drugs" for Promotion of Resilience Against Stress-Induced Depression and Cognitive Impairment.
Ward L; Pasinetti GM
Neuromolecular Med; 2016 Sep; 18(3):487-95. PubMed ID: 27342633
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: emerging issues.
Rietjens IM; Slob W; Galli C; Silano V
Toxicol Lett; 2008 Aug; 180(2):131-6. PubMed ID: 18602975
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and toxicological considerations of botanicals in anticancer therapy.
Fimognari C; Ferruzzi L; Turrini E; Carulli G; Lenzi M; Hrelia P; Cantelli-Forti G
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):819-32. PubMed ID: 22540949
[TBL] [Abstract][Full Text] [Related]
8. Botanicals as modulators of depression and mechanisms involved.
Zhang Z; Deng T; Wu M; Zhu A; Zhu G
Chin Med; 2019; 14():24. PubMed ID: 31338119
[TBL] [Abstract][Full Text] [Related]
9. Botanicals in dermatology: an evidence-based review.
Reuter J; Merfort I; Schempp CM
Am J Clin Dermatol; 2010; 11(4):247-67. PubMed ID: 20509719
[TBL] [Abstract][Full Text] [Related]
10. Role of reactive oxygen species in the anticancer activity of botanicals: Comparing sensitivity profiles.
Cohen Z; Maimon Y; Samuels N; Berger R
Oncol Lett; 2017 Apr; 13(4):2642-2648. PubMed ID: 28454445
[TBL] [Abstract][Full Text] [Related]
11. Threshold of toxicological concern (TTC) for botanicals - Concentration data analysis of potentially genotoxic constituents to substantiate and extend the TTC approach to botanicals.
Mahony C; Bowtell P; Huber M; Kosemund K; Pfuhler S; Zhu T; Barlow S; McMillan DA
Food Chem Toxicol; 2020 Apr; 138():111182. PubMed ID: 32058013
[TBL] [Abstract][Full Text] [Related]
12. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.
Shord SS; Shah K; Lukose A
Integr Cancer Ther; 2009 Sep; 8(3):208-27. PubMed ID: 19815591
[TBL] [Abstract][Full Text] [Related]
13. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals.
Possemiers S; Bolca S; Verstraete W; Heyerick A
Fitoterapia; 2011 Jan; 82(1):53-66. PubMed ID: 20655994
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
Cefalu WT; Ye J; Wang ZQ
Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):78-81. PubMed ID: 18537692
[TBL] [Abstract][Full Text] [Related]
15. Botanicals used in complementary and alternative medicine treatment of cancer: clinical science and future perspectives.
Miller S; Stagl J; Wallerstedt DB; Ryan M; Mansky PJ
Expert Opin Investig Drugs; 2008 Sep; 17(9):1353-64. PubMed ID: 18694368
[TBL] [Abstract][Full Text] [Related]
16. Botanicals and phytochemicals active on cognitive decline: The clinical evidence.
Cicero AFG; Fogacci F; Banach M
Pharmacol Res; 2018 Apr; 130():204-212. PubMed ID: 29289576
[TBL] [Abstract][Full Text] [Related]
17. A multi-criteria decision analysis model to assess the safety of botanicals utilizing data on history of use.
Neely T; Walsh-Mason B; Russell P; Horst AV; O'Hagan S; Lahorkar P
Toxicol Int; 2011 Aug; 18(Suppl 1):S20-9. PubMed ID: 22025816
[TBL] [Abstract][Full Text] [Related]
18. In silico approach to safety of botanical dietary supplement ingredients utilizing constituent-level characterization.
Little JG; Marsman DS; Baker TR; Mahony C
Food Chem Toxicol; 2017 Sep; 107(Pt A):418-429. PubMed ID: 28698155
[TBL] [Abstract][Full Text] [Related]
19. Review of the use of botanicals for epilepsy in complementary medical systems--Traditional Chinese Medicine.
Xiao F; Yan B; Chen L; Zhou D
Epilepsy Behav; 2015 Nov; 52(Pt B):281-9. PubMed ID: 26052078
[TBL] [Abstract][Full Text] [Related]
20. Induction of EpRE-mediated gene expression by a series of mediterranean botanicals and their constituents.
Papadi G; Wesseling S; Troganis AN; Vervoort J; Rietjens IMCM
J Ethnopharmacol; 2019 Aug; 240():111940. PubMed ID: 31071423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
